Skip to content
Winnowleaf home

Condition

Liver Cancer

Hepatocellular carcinoma is the most common primary liver cancer, usually starting in a liver already damaged by long-term disease such as hepatitis or cirrhosis. Among supplements, vitamin K has the clearest research, and studies found cancer deaths were lower, with the evidence rated moderate. Those studies were small, and they looked at cancer mortality only, so they say little about other outcomes.

Supplements studied
2
Graded outcomes
1
Trials
3
People studied
2,155

Evidence by supplement

  • Strong
  • Moderate
  • Limited
  • Very limited

2 supplements

Vitamin K: outcomes studied for Liver Cancer
GradeOutcomeEffectSizeStudiesPeopleStudies list
Cancer Mortality

Small Improvement

Improves (the measure goes down)Small effect1,980 people
Liver Cancer RiskChanges; see studies3 studies1,980 people
Saffron: outcomes studied for Liver Cancer
GradeOutcomeEffectSizeStudiesPeopleStudies list
Cancer MetastasisImproves (the measure goes up)1 study13 people

Key findings

  • Cancer MortalityVitamin KImproves (the measure goes down)

The Liver Cancer (Hepatocellular Carcinoma) Supportive Care protocol

2 primary supplements · 6 supporting supplements

See the full protocol

Studies cited

4 studies from PubMed

  1. The effect of menatetrenone, a vitamin K2 analog, on disease recurrence and survival in patients with hepatocellular carcinoma after curative treatment: a pilot studyCancer · PMID 16400650
  2. Effect of menatetrenone, a vitamin k2 analog, on recurrence of hepatocellular carcinoma after surgical resection: a prospective randomized controlled trialAnticancer Res · PMID 23225445
  3. The Efficacy of Vitamin K, A Member Of Naphthoquinones in the Treatment of Cancer: A Systematic Review and Meta-AnalysisCurr Cancer Drug Targets · PMID 33475062
  4. Effect of saffron on liver metastases in patients suffering from cancers with liver metastases: A randomized, double blind, placebo-controlled clinical trialAvicenna J Phytomed · PMID 26468463